2 min.Read

Can Medicines Inject the Vitamins Amazon is Missing?

August 1, 2025

How Amazon’s Healthcare Bet May Change Indian Diagnostics and Digital Health

Introduction

Amazon, the world’s largest e-commerce player, is eyeing a massive new opportunity: healthcare. Its bold foray into diagnostics, pharmacy, and virtual consultations—especially in India—signals a push beyond packages and electronics into one of the world’s most vital and fragmented industries[1].

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Topics

Mounjaro Shows Heart-Health Benefits in Major Diabetes Study

Incentives in Healthcare: The Quiet Force Shaping Outcomes

Can Medicines Inject the Vitamins Amazon is Missing?

Introduction

Free Membership Required

The $1.5 Billion Question in Hyderabad: Orbicular, Peptides and the PE Re-Rating of Indian Complex Generics

Medical Reps—Lessons From The West: The Old Model is Dead

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

Pharmacy of the World Pricing Paradox

Topics

The $1.5 Billion Question in Hyderabad: Orbicular, Peptides and the PE Re-Rating of Indian Complex Generics

Medical Reps—Lessons From The West: The Old Model is Dead

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

Pharmacy of the World Pricing Paradox

Why The Government Must Stop Playing Market Trader And Start Being The Sheriff

MedicinMan Pharma Pulse: August 2026

GLP-1: When the Molecule Becomes a Commodity, What Becomes the Moat?

Related Articles

Medical Reps—Lessons From The West: The Old Model is Dead

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

Pharmacy of the World Pricing Paradox

Why The Government Must Stop Playing Market Trader And Start Being The Sheriff

GLP-1: When the Molecule Becomes a Commodity, What Becomes the Moat?

Company

Headlines

The $1.5 Billion Question in Hyderabad: Orbicular, Peptides and the PE Re-Rating of Indian Complex Generics

Medical Reps—Lessons From The West: The Old Model is Dead

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

Newsletter